Research Paper Volume 16, Issue 2 pp 1696—1711
Therapeutic strategies and predictive models for Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma in adults based on data of two Chinese medical centers
Figure 4. Decision curve analysis. DCA curve analysis of the training cohort (A) and external validation (B). Quantified net benefits were measured for different threshold probabilities. The y-axis denotes the standardized net benefit, and the x-axis denotes the threshold probabilities. The red line represents our nomogram, the blue line represents the condition of patients with TFE3-RCC, and the black line represents the condition of which none suffered from TFE3-RCC.